PMID- 26932374 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20160302 LR - 20200928 IS - 2001-1326 (Print) IS - 2001-1326 (Electronic) IS - 2001-1326 (Linking) VI - 3 IP - 1 DP - 2014 Dec TI - Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma. PG - 28 LID - 10.1186/s40169-014-0028-z [doi] LID - 28 AB - BACKGROUND: Snail, a transcriptional factor and repressor of E-cadherin is well known for its role in cellular invasion. It can regulate epithelial to mesenchymal transition (EMT) during embryonic development and in epithelial cells. Snail also mediates tumor progression and metastases. Silencing of Snail and its associate member Slug in human A2780 ovarian epithelial carcinoma cell line was investigated to identify its role in tumor neovascularization. METHODS: Live cell sialidase, WST-1 cell viability and immunohistochemistry assays were used to evaluate sialidase activity, cell survival and the expression levels of tumor E-cadherin, N-cadherin, VE-cadherin, and host endothelial CD31+(PECAM-1) cells in archived paraffin-embedded ovarian A2780, A2780 Snail shRNA GIPZ lentiviral knockdown (KD) and A2780 Slug shRNA GIPZ lentiviral KD tumors grown in RAGxCgamma double mutant mice. RESULTS: Oseltamivir phosphate (OP), anti-Neu1 antibodies and MMP-9 specific inhibitor blocked Neu1 activity associated with epidermal growth factor (EGF) stimulated A2780 ovarian epithelial carcinoma cells. Silencing Snail in A2780 cells abrogated the Neu1 activity following EGF stimulation of the cells compared to A2780 and A2780 Slug KD cells. OP treatment of A2780 and cisplatin-resistant A2780cis cells reproducibly and dose-dependently abated the cell viability with a LD50 of 7 and 4 mum, respectively, after 48 h of incubation. Heterotopic xenografts of A2780 and A2780 Slug KD tumors developed robust and bloody tumor vascularization in RAG2xCgamma double mutant mice. OP treatment at 50 mg/kg daily intraperitoneally did not significantly impede A2780 tumor growth rate but did cause a significant reduction of lung metastases compared with the untreated and OP 30mg/kg cohorts. Silencing Snail in A2780 tumor cells completely abrogated tumor vascularization, tumor growth and spread to the lungs in RAGxCgamma double mutant mice. A2780 and A2780 Slug KD tumors expressed high levels of human N- and VE-cadherins, and host CD31+ endothelial cells, while A2780 Snail KD tumors expressed E-cadherin and reduced host CD31+ cells. OP 50mg/kg cohort tumors had reduced numbers of host CD31+ cells compared to a higher expression levels of CD31+ cells in tumors from the untreated control and OP 30mg/kg cohorts. CONCLUSION: Snail transcriptional factor is an important intermediate player in human ovarian tumor neovascularization. FAU - Abdulkhalek, Samar AU - Abdulkhalek S AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. samarma@hotmail.com. AD - Present address: Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA. samarma@hotmail.com. FAU - Geen, Olivia D AU - Geen OD AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. 9odg@queensu.ca. FAU - Brodhagen, Lacey AU - Brodhagen L AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. lbrodhagen12@hotmail.com. FAU - Haxho, Fiona AU - Haxho F AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. 9fh3@queensu.ca. FAU - Alghamdi, Farah AU - Alghamdi F AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. farah_gg@hotmail.com. AD - Present address: The King Fahd Armed Forces Hospital, Serology, Jeddah, Saudi Arabia. farah_gg@hotmail.com. FAU - Allison, Stephanie AU - Allison S AD - Chemical Engineering, Queen's University, Kingston, K7L 3N6, ON, Canada. Stephanie.allison@chee.queensu.ca. FAU - Simmons, Duncan J AU - Simmons DJ AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. duncan4@hotmail.ca. FAU - O'Shea, Leah K AU - O'Shea LK AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. lkoshea4@gmail.com. AD - Present address: Mississauga Academy of Medicine, University of Toronto Mississauga, North Terrence Donnelly Health Sciences Complex, Mississauga, L5L 1C6, ON, Canada. lkoshea4@gmail.com. FAU - Neufeld, Ronald J AU - Neufeld RJ AD - Chemical Engineering, Queen's University, Kingston, K7L 3N6, ON, Canada. neufeld@queensu.ca. FAU - Szewczuk, Myron R AU - Szewczuk MR AD - Departments of Biomedical and Molecular Sciences, Queen's University, Kingston, K7L 3N6, ON, Canada. szewczuk@queensu.ca. LA - eng PT - Journal Article DEP - 20140923 PL - United States TA - Clin Transl Med JT - Clinical and translational medicine JID - 101597971 PMC - PMC4884043 OTO - NOTNLM OT - Human ovarian cancer OT - Oseltamivir phosphate OT - Silencing transcriptional repressors Snail and Slug OT - Tumor neovascularization EDAT- 2014/12/01 00:00 MHDA- 2014/12/01 00:01 PMCR- 2014/09/23 CRDT- 2016/03/03 06:00 PHST- 2014/06/21 00:00 [received] PHST- 2014/07/24 00:00 [accepted] PHST- 2016/03/03 06:00 [entrez] PHST- 2014/12/01 00:00 [pubmed] PHST- 2014/12/01 00:01 [medline] PHST- 2014/09/23 00:00 [pmc-release] AID - 10.1186/s40169-014-0028-z [pii] AID - 28 [pii] AID - 10.1186/s40169-014-0028-z [doi] PST - ppublish SO - Clin Transl Med. 2014 Dec;3(1):28. doi: 10.1186/s40169-014-0028-z. Epub 2014 Sep 23.